Oye Therepeutics
Pharmaceutical, development stage, company
Based in IN
AI Overview
With $540K in lobbying spend across 21 quarterly filings, Oye Therepeutics is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $100K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $120K |
| 2025 | $80K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Oye Therepeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Government affairs and communication services
General Consulting
General Consulting and informing federal agencies and Congress on the research that OYE Therapeutics is currently doing.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.